Skip to content

Comparison of induction of abortion in both inpatients and outpatients in the first trimester of pregnancy

Comparison of successes and complications of inpatient and outpatient treatment in the first trimester abortion with misoprostol

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180109038284N1
Enrollment
140
Registered
2019-06-25
Start date
2017-11-22
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induction of abortion in the first trimester as an outpatient with misoprostol.

Interventions

Intervention 1: Intervention group: In the first group (inpatients), 800 micrograms of vaginal misoprostol are given every 12 hours to 3 doses. In the event of fever (T=38 ° C), a prescription for ace

Sponsors

Research Council of Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Pregnant woman with indication of abortion in the first trimester of pregnancy (less than 14 weeks based on sonography and LMP) Stable hemodynamic conditions Patients living with the family Ability to move quickly to the hospital

Exclusion criteria

Exclusion criteria: The presence of heart, lung, kidney, liver disease Uncontrolled seizures Hemoglobin is less than 10 IUD in the womb Coagulation disorder Severe bleeding Fever or signs of infectious abortion Misoprostol sensitivity

Design outcomes

Primary

MeasureTime frame
The success rate of spontaneous abortion with misoprostol administration (no need for curettage). Timepoint: After intervention up to 2 weeks. Method of measurement: Questionnaire and ultrasound to evaluation of fetal and placental abortion.

Secondary

MeasureTime frame
Patient satisfactory. Timepoint: after intervention up to 2 weeks. Method of measurement: check-list (Outcome of treatment, Physical and mental satisfaction, Costs spent).;The success rate of treatment without any other medical intervention. Timepoint: after intervention up to 2 weeks. Method of measurement: check-list (outcome of treatment, rang of hemoglobin).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtiyeh Mohamadzade Vatanchi

Mashhad University of Medical Sciences

vatanchia@mums.ac.ir+98 51 3801 2477

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026